Study of ESG406 in Adults With Solid Tumors

NCT06979674 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

556

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced/Metastatic Solid Tumors

Interventions

DRUG: ESG406

Sponsor

Shanghai Escugen Biotechnology Co., Ltd